Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of bladder cancer in older patients.
Hatakeyama S, Narita S, Okita K, Narita T, Iwamura H, Fujita N, Inokuchi J, Matsui Y, Kitamura H, Ohyama C. Hatakeyama S, et al. Among authors: narita s, narita t. Jpn J Clin Oncol. 2022 Mar 3;52(3):203-213. doi: 10.1093/jjco/hyab187. Jpn J Clin Oncol. 2022. PMID: 34905776
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C. Kusaka A, et al. Among authors: narita t. Med Oncol. 2017 May;34(5):90. doi: 10.1007/s12032-017-0955-9. Epub 2017 Apr 10. Med Oncol. 2017. PMID: 28397105
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Fujita N, et al. Among authors: narita t. Urol Oncol. 2020 Aug;38(8):684.e17-684.e24. doi: 10.1016/j.urolonc.2020.03.009. Epub 2020 Apr 9. Urol Oncol. 2020. PMID: 32278732
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Fujita N, et al. Among authors: narita t. Urol Oncol. 2021 Mar;39(3):191.e9-191.e16. doi: 10.1016/j.urolonc.2020.06.032. Epub 2020 Jul 23. Urol Oncol. 2021. PMID: 32713622
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.
Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Fujita N, et al. Among authors: narita t. Int J Urol. 2022 Aug;29(8):867-875. doi: 10.1111/iju.14926. Epub 2022 May 16. Int J Urol. 2022. PMID: 35577361
Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C. Hatakeyama S, et al. Among authors: narita t. PLoS One. 2016 Feb 22;11(2):e0149544. doi: 10.1371/journal.pone.0149544. eCollection 2016. PLoS One. 2016. PMID: 26901860 Free PMC article.
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Narita T, Koie T, Ookubo T, Mitsuzuka K, Narita S, Yamamoto H, Inoue T, Hatakeyama S, Kawamura S, Tochigi T, Habuchi T, Arai Y, Ohyama C. Narita T, et al. Among authors: narita s. Med Oncol. 2017 Jan;34(1):1. doi: 10.1007/s12032-016-0859-0. Epub 2016 Nov 26. Med Oncol. 2017. PMID: 27889880
Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
Hamano I, Hatakeyama S, Iwamurau H, Fujita N, Fukushi K, Narita T, Hagiwara K, Kusaka A, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C. Hamano I, et al. Among authors: narita t. Oncotarget. 2017 May 29;8(37):61404-61414. doi: 10.18632/oncotarget.18248. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977873 Free PMC article.
Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Hagiwara K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C. Kusaka A, et al. Among authors: narita t. Oncotarget. 2017 Jul 6;8(39):65492-65505. doi: 10.18632/oncotarget.19043. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029448 Free PMC article.
758 results